CJC-1295 DAC dosage protocols leverage this long-acting growth hormone-releasing hormone (GHRH) analog’s unique albumin-binding technology, which extends its half-life to approximately 6–8 days[1][2]. By stimulating pulsatile growth hormone (GH) release while preserving natural GH rhythms, CJC-1295 DAC can elevate GH levels 2–10 fold and IGF-1 levels 1.5–3 fold in human studies[3]. Benefits may include enhanced muscle growth and recovery, improved fat metabolism, better sleep quality, and anti-aging effects through sustained GH/IGF-1 axis activation[4][5]. This educational protocol presents a once-weekly subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
- Reconstituir: Adicione 1,0 mL de água bacteriostática → concentração de 2,0 mg/mL (2.000 mcg/mL).
- Dose semanal típica: 2.000 mcg (2 mg) uma vez por semana - o frasco completo por injeção.
- Medição fácil: A 2,0 mg/mL, 1 unidade = 0,01 mL = 20 mcg em uma seringa de insulina U-100; dose total = 100 unidades (1,00 mL).
- Armazenamento: Liofilizado: congelar a −20 °C (−4 °F); após a reconstituição, refrigerar a 2–8 °C (35,6–46,4 °F); evitar ciclos de congelamento-descongelamento.
